Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sigilon Therapeutics Inc (NQ: SGTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 21.95 (1)
Ask (Size) 23.18 (1)
Prev. Close 22.47
Today's Range N/A - N/A
52wk Range 20.61 - 23.79
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why These 3 Large Caps Are Bucking the August Slump
The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023. 
Via MarketBeat
Topics Economy Stocks
Exposures Fossil Fuels Interest Rates US Equities
Over $25M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades. 
Via Benzinga

Performance

More News

Read More
Eli Lilly To Report Q2 Earnings: What's In The Cards?
Via Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
Sigilon Therapeutics Inc. (NASDAQ: SGTX) Near the Top of Equities by Percentage Gain on 6/29
Via Investor Brand Network
Health Care Company Eli Lilly Announces Acquisition of Sigilon Therapeutics
Via Benzinga
SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX
From Kahn Swick & Foti, LLC
Via Business Wire
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
Via Benzinga
Tesla, Nike, Sigilon Therapeutics Among Top Trending Stocks Today
Via Benzinga
Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates
Via Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Edges Higher; McCormick Posts Upbeat Earnings
Via Benzinga
Dow Rises Over 100 Points; US GDP Grows 2% In Q1
Via Benzinga
Sigilon Therapeutics Scores Eli Lilly Buyout And Skyrockets More Than 500%
Via Investor's Business Daily
Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On
Via Benzinga
Why Is Cormedix (CRMD) Stock Down 23% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today?
Via InvestorPlace
SGTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sigilon Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Is Eco Wave Power Global (WAVE) Stock Up 58% Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.